375 related articles for article (PubMed ID: 22126709)
1. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation.
Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C
Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.
Sun F; Sui C; Zhou Y; Liu X; Shi Y; Wu Y; Li Y
Int J Pharm; 2013 Sep; 454(1):532-8. PubMed ID: 23891744
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
Prasanthi D; Lakshmi PK
Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
[TBL] [Abstract][Full Text] [Related]
5. Design of transparent film-forming hydrogels of tolterodine and their effects on stratum corneum.
Liu X; Fu L; Dai W; Liu W; Zhao J; Wu Y; Teng L; Sun F; Li Y
Int J Pharm; 2014 Aug; 471(1-2):322-31. PubMed ID: 24882035
[TBL] [Abstract][Full Text] [Related]
6. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
7. Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies.
Elshafeey AH; Kamel AO; Fathallah MM
Pharm Res; 2009 Nov; 26(11):2446-53. PubMed ID: 19697106
[TBL] [Abstract][Full Text] [Related]
8. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
9. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
10. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
[TBL] [Abstract][Full Text] [Related]
11. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
Liu C; Fang L
AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739
[TBL] [Abstract][Full Text] [Related]
12. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
[TBL] [Abstract][Full Text] [Related]
13. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
Hu Y; Wu YY; Xia XJ; Wu Z; Liang WQ; Gao JQ
Drug Deliv; 2011 Jan; 18(1):84-9. PubMed ID: 20939674
[TBL] [Abstract][Full Text] [Related]
14. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
15. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
17. Novel silicone-based adhesive technology for transdermal therapy systems.
Schalau GK; Huber RO; Nartker LS; Thomas X
Ther Deliv; 2017 Apr; 8(4):175-178. PubMed ID: 28162040
[No Abstract] [Full Text] [Related]
18. Tolterodine extended-release for overactive bladder.
Chung DE; Te AE
Expert Opin Pharmacother; 2009 Sep; 10(13):2181-94. PubMed ID: 19663610
[TBL] [Abstract][Full Text] [Related]
19. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Pradhan R; Kim YI; Chang SW; Kim JO
Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
